Wesfarmers Ltd (ASX:WES)
Wesfarmers Ltd (ASX:WES) is a 100-year-old conglomerate which at various times has owned and operated some of Australia’s largest retail brands such as Kmart, Target and more. Today, its largest business is Bunnings Warehouse, the number-one DIY home improvement business.
Wesfarmers Ltd (ASX:WES) share price
Wesfarmers Ltd (ASX:WES) passive income
Wesfarmers Ltd (ASX:WES) share price news
Wesfarmers (ASX:WES) share price on watch after profit and dividend cut
The Wesfarmers Ltd (ASX: WES) share price will be on watch today after announcing a 14% fall in profit for the first half of FY22.
Watchlist Wednesday: Wesfarmers Ltd (ASX:WES)
Today’s Watchlist Wednesday looks at one of the most well-known yet misunderstood companies on the ASX, Wesfarmers Ltd (ASX: WES).
Is the Wesfarmers (ASX:WES) share price too cheap to ignore?
The Wesfarmers Ltd (ASX:WES) share price has fallen to around a six-month low. Is it now too cheap to ignore?
ASX 200 morning report – WES, B4P & PPS shares in focus
The S&P/ASX 200 (ASX:XJO) started the week on a solid footing as Wesfarmers (ASX:WES) and Beforepay (ASX:B4P) shares made headlines.
Wesfarmers (ASX:WES) share price up despite 13% profit decline
The Wesfarmers Ltd (ASX: WES) share price is moving higher today despite profit for the half reversing 13% due to mandated pandemic closures.
Australian Pharmaceutical (ASX:API) share price sinks as Woolworths withdraws $1.75 bid
Woolworths Group Ltd (ASX: WOW) today announced it has withdrawn its $1.75 per share offer for Australian Pharmaceutical Industries Ltd (ASX: API).
2 ASX shares I’d buy in January 2022
I have my eyes on a number of quality ASX shares that look like long-term opportunities, including Metcash Limited (ASX:MTS).
ASX 200 set to rise – WES, WOW & CTD shares in focus
The S&P/ASX 200 (ASX:XJO) dropped 0.7% on Thursday as Wesfarmers (ASX:WES) and Corporate Travel (ASX:CTD) shares make headlines.
Wesfarmers (ASX:WES) share price on watch with API update
The Wesfarmers Ltd (ASX:WES) share price is in focus as it announced an update with the Australian Pharmaceutical Industries (ASX:API) bid.